CD163 and COVID-19: In addition, in COVID-19 blood monocytes display an activated phenotype (i.e., CD11b/CD16/CD66bhigh), and CD163/CD206low monocytes are decreased in severe compared to mild COVID-19, also suggesting a more activated phenotype [16].